- Home
- ASYS vs ACET Comparison
ASYS vs ACET Comparison
Compare ASYS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- ACET
- Stock Information
- Founded
- ASYS 1981
- ACET 1947
- Country
- ASYS United States
- ACET United States
- Employees
- ASYS N/A
- ACET N/A
- Industry
- ASYS Industrial Machinery/Components
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- ACET Health Care
- Exchange
- ASYS Nasdaq
- ACET Nasdaq
- Market Cap
- ASYS 83.0M
- ACET 69.9M
- IPO Year
- ASYS N/A
- ACET N/A
- Fundamental
- Price
- ASYS $7.77
- ACET $1.03
- Analyst Decision
- ASYS
- ACET Buy
- Analyst Count
- ASYS 0
- ACET 4
- Target Price
- ASYS N/A
- ACET $6.00
- AVG Volume (30 Days)
- ASYS 403.0K
- ACET 2.4M
- Earning Date
- ASYS 08-06-2025
- ACET 11-05-2025
- Dividend Yield
- ASYS N/A
- ACET N/A
- EPS Growth
- ASYS N/A
- ACET N/A
- EPS
- ASYS N/A
- ACET N/A
- Revenue
- ASYS $83,634,000.00
- ACET N/A
- Revenue This Year
- ASYS N/A
- ACET N/A
- Revenue Next Year
- ASYS $12.93
- ACET N/A
- P/E Ratio
- ASYS N/A
- ACET N/A
- Revenue Growth
- ASYS N/A
- ACET N/A
- 52 Week Low
- ASYS $3.20
- ACET $0.45
- 52 Week High
- ASYS $10.80
- ACET $1.54
- Technical
- Relative Strength Index (RSI)
- ASYS 42.89
- ACET 64.54
- Support Level
- ASYS $8.76
- ACET $0.90
- Resistance Level
- ASYS $10.80
- ACET $1.09
- Average True Range (ATR)
- ASYS 0.87
- ACET 0.09
- MACD
- ASYS -0.32
- ACET 0.01
- Stochastic Oscillator
- ASYS 3.50
- ACET 78.44
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.